<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName journalpublishing.dtd?>
<?SourceDTD.Version 2.3?>
<?ConverterInfo.XSLTName jp2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Front Chem</journal-id>
    <journal-id journal-id-type="iso-abbrev">Front Chem</journal-id>
    <journal-id journal-id-type="publisher-id">Front. Chem.</journal-id>
    <journal-title-group>
      <journal-title>Frontiers in Chemistry</journal-title>
    </journal-title-group>
    <issn pub-type="epub">2296-2646</issn>
    <publisher>
      <publisher-name>Frontiers Media S.A.</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">7010641</article-id>
    <article-id pub-id-type="doi">10.3389/fchem.2020.00046</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Chemistry</subject>
        <subj-group>
          <subject>Original Research</subject>
        </subj-group>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>ChEMBL-Likeness Score and Database GDBChEMBL</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Bühlmann</surname>
          <given-names>Sven</given-names>
        </name>
        <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/868730/overview"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Reymond</surname>
          <given-names>Jean-Louis</given-names>
        </name>
        <xref ref-type="corresp" rid="c001">
          <sup>*</sup>
        </xref>
        <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/759784/overview"/>
      </contrib>
    </contrib-group>
    <aff><institution>Department of Chemistry and Biochemistry, University of Bern</institution>, <addr-line>Bern</addr-line>, <country>Switzerland</country></aff>
    <author-notes>
      <fn fn-type="edited-by">
        <p>Edited by: Jose L. Medina-Franco, National Autonomous University of Mexico, Mexico</p>
      </fn>
      <fn fn-type="edited-by">
        <p>Reviewed by: Cristian G. Bologa, University of New Mexico, United States; Rodrigo Ochoa, University of Antioquia, Colombia</p>
      </fn>
      <corresp id="c001">*Correspondence: Jean-Louis Reymond <email>jean-louis.reymond@dcb.unibe.ch</email></corresp>
      <fn fn-type="other" id="fn001">
        <p>This article was submitted to Medicinal and Pharmaceutical Chemistry, a section of the journal Frontiers in Chemistry</p>
      </fn>
    </author-notes>
    <pub-date pub-type="epub">
      <day>04</day>
      <month>2</month>
      <year>2020</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2020</year>
    </pub-date>
    <volume>8</volume>
    <elocation-id>46</elocation-id>
    <history>
      <date date-type="received">
        <day>25</day>
        <month>10</month>
        <year>2019</year>
      </date>
      <date date-type="accepted">
        <day>15</day>
        <month>1</month>
        <year>2020</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>Copyright © 2020 Bühlmann and Reymond.</copyright-statement>
      <copyright-year>2020</copyright-year>
      <copyright-holder>Bühlmann and Reymond</copyright-holder>
      <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
        <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
      </license>
    </permissions>
    <abstract>
      <p>The generated database GDB17 enumerates 166.4 billion molecules up to 17 atoms of C, N, O, S and halogens following simple rules of chemical stability and synthetic feasibility. However, most molecules in GDB17 are too complex to be considered for chemical synthesis. To address this limitation, we report GDBChEMBL as a subset of GDB17 featuring 10 million molecules selected according to a ChEMBL-likeness score (CLscore) calculated from the frequency of occurrence of circular substructures in ChEMBL, followed by uniform sampling across molecular size, stereocenters and heteroatoms. Compared to the previously reported subsets FDB17 and GDBMedChem selected from GDB17 by fragment-likeness, respectively, medicinal chemistry criteria, our new subset features molecules with higher synthetic accessibility and possibly bioactivity yet retains a broad and continuous coverage of chemical space typical of the entire GDB17. GDBChEMBL is accessible at <ext-link ext-link-type="uri" xlink:href="http://gdb.unibe.ch">http://gdb.unibe.ch</ext-link> for download and for browsing using an interactive chemical space map at <ext-link ext-link-type="uri" xlink:href="http://faerun.gdb.tools">http://faerun.gdb.tools</ext-link>.</p>
    </abstract>
    <kwd-group>
      <kwd>chemical space exploration</kwd>
      <kwd>molecular database</kwd>
      <kwd>enumeration algorithm</kwd>
      <kwd>chemical space mapping</kwd>
      <kwd>virtual screening</kwd>
    </kwd-group>
    <funding-group>
      <award-group>
        <funding-source id="cn001">Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung<named-content content-type="fundref-id">10.13039/501100001711</named-content></funding-source>
      </award-group>
    </funding-group>
    <counts>
      <fig-count count="3"/>
      <table-count count="0"/>
      <equation-count count="1"/>
      <ref-count count="35"/>
      <page-count count="7"/>
      <word-count count="4032"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec sec-type="intro" id="s1">
    <title>Introduction</title>
    <p>Innovation at the level of chemical structures is an essential part of drug discovery. Novelty often results from chemical intuition however this approach is increasingly difficult as the number of known molecules increases. Novelty is similarly limited in virtual combinatorial libraries (Leach and Hann, <xref rid="B19" ref-type="bibr">2000</xref>; Hu et al., <xref rid="B16" ref-type="bibr">2011</xref>; van Hilten et al., <xref rid="B33" ref-type="bibr">2019</xref>) and generative models trained with known molecules (Chen et al., <xref rid="B9" ref-type="bibr">2018</xref>; Elton et al., <xref rid="B11" ref-type="bibr">2019</xref>) because these systems mostly shuffle known patterns, which produces many technically new but often not fundamentally innovative molecules. To circumvent this limitation, we have initiated the exhaustive enumeration of all possible organic molecules following simple rules of chemical stability and synthetic feasibility, and reported large databases enumerating molecules up to 11 (Fink et al., <xref rid="B13" ref-type="bibr">2005</xref>; Fink and Reymond, <xref rid="B14" ref-type="bibr">2007</xref>), 13 (Blum and Reymond, <xref rid="B8" ref-type="bibr">2009</xref>), and 17 atoms (Ruddigkeit et al., <xref rid="B31" ref-type="bibr">2012</xref>, <xref rid="B30" ref-type="bibr">2013</xref>), as well as of possible ring systems up to 30 atoms (Visini et al., <xref rid="B34" ref-type="bibr">2017a</xref>). Analyzing the resulting generated databases (GDBs) shows that there are many orders of magnitude more possible molecules spanning a much broader structural diversity than already known ones (Reymond, <xref rid="B27" ref-type="bibr">2015</xref>; Awale et al., <xref rid="B6" ref-type="bibr">2017b</xref>).</p>
    <p>One of the defining features of the GDB databases is the exponential increase in the number of possible molecules as function of increasing molecular size and complexity elements, such as stereocenters and heteroatoms, implying that most possible molecules are in fact far too complex to be considered as realistic synthetic targets. To address this problem we have designed subsets of our largest database GDB17 by limiting complexity elements using simplification criteria, such as fragment-likeness (Congreve et al., <xref rid="B10" ref-type="bibr">2003</xref>), producing the fragment database FDB17, and medicinal chemistry rules for functional groups and complexity (Mignani et al., <xref rid="B21" ref-type="bibr">2018</xref>), producing the medicinal chemistry aware database GDBMedChem (Visini et al., <xref rid="B35" ref-type="bibr">2017b</xref>; Awale et al., <xref rid="B5" ref-type="bibr">2019</xref>). These approaches however also constrain the diversity of GDB molecules, which partly defeats the purpose of exploring chemical space broadly.</p>
    <p>Herein we report an alternative approach to create subsets of GDB17 based on the frequency of occurrence of substructures from known molecules independent of the overall molecular structure (<xref ref-type="fig" rid="F1">Figure 1A</xref>). We define a “ChEMBL-likeness” score (CLscore) by considering which substructures in a molecule also occur in molecules from the public database ChEMBL (Gaulton et al., <xref rid="B15" ref-type="bibr">2017</xref>), using a subset of molecules with reported high confidence datapoint of activity on single protein targets, a type of ChEMBL subset which we have used previously for target prediction (Awale and Reymond, <xref rid="B2" ref-type="bibr">2019</xref>; Poirier et al., <xref rid="B23" ref-type="bibr">2019</xref>). We then filter the entire GDB17 with a cut-off value for CLscore, followed by uniform sampling of the resulting subset across molecular size, stereocenters and heteroatoms as done previously with FDB17 and GDBMedChem, to obtain a ChEMBL-like subset of 10 million molecules forming the database GDBChEMBL. This database covers chemical space as broadly as but more continuously than FDB17 and GDBMedChem yet features a much higher synthetic accessibility as judged by a calculated synthetic accessibility score (Ertl and Schuffenhauer, <xref rid="B12" ref-type="bibr">2009</xref>), might contain molecules with a higher probability of bioactivity, and in any case provides a very different starting point to serve as a source of inspiration for molecular design.</p>
    <fig id="F1" position="float">
      <label>Figure 1</label>
      <caption>
        <p><bold>(A)</bold> Generation process of GDBChEMBL. <bold>(B)</bold> CLscore distributions for GDB17, its subsets FDB17 and GDBMedChem, and public databases ChEMBL, ZINC, and DrugBank. <bold>(C)</bold> Frequency distribution of molecular shingles up to a diameter of 6 bonds in ChEMBL. <bold>(D)</bold> SAscore vs. CLscore in various databases. A lower SAscore indicates higher synthetic accessibility, and a higher CLscore indicates higher similarity to ChEMBL molecules. <bold>(E)</bold> Occupancy of triplet value bins (HAC, stereocenters, heteroatoms) in all GDB17 cpds with CLscore ≥3.3 (black line) and after uniform sampling forming GDBChEMBL (red line).</p>
      </caption>
      <graphic xlink:href="fchem-08-00046-g0001"/>
    </fig>
  </sec>
  <sec id="s2">
    <title>Results and Discussion</title>
    <sec>
      <title>ChEMBL-Likeness Score</title>
      <p>Our definition of CLscore is related to the synthetic accessibility score (SAscore) (Ertl and Schuffenhauer, <xref rid="B12" ref-type="bibr">2009</xref>) and natural product likeness score (NPscore) (Jayaseelan et al., <xref rid="B17" ref-type="bibr">2012</xref>) of a molecule, which are calculated from the occurrence frequencies of its substructures in PubChem and fragments from natural products, respectively, combined with additional functional group rules. Here we focus on 457,139 compounds recorded in ChEMBL24 as being active on single protein targets (IC<sub>50</sub> or EC<sub>50</sub> ≤ 10 μM) with high confidence datapoints (Awale and Reymond, <xref rid="B2" ref-type="bibr">2019</xref>; Poirier et al., <xref rid="B23" ref-type="bibr">2019</xref>). To design our CLscore we consider circular substructures, called molecular shingles, because they form the basis for molecular fingerprints ECFP4 and MHFP6 which perform best in benchmarking studies (Riniker and Landrum, <xref rid="B28" ref-type="bibr">2013</xref>; Probst and Reymond, <xref rid="B24" ref-type="bibr">2018</xref>).</p>
      <p>The frequency of occurrence of the 636,979 molecular shingles up to a diameter of six bonds found in our ChEMBL subset follows a power law distribution (<xref ref-type="fig" rid="F1">Figure 1C</xref>). To compute the CLscore of a molecule, we assign to each of its shingles (S) a shingle value calculated from the logarithm of its frequency of occurrence f<sub>S</sub> in our ChEMBL subset, considering only shingles occurring at least 100 times in this subset (141,261 shingles, 22.2% of the total). We then sum all shingle values and divide the sum by the total number of shingles in the molecule (Equation 1).</p>
      <disp-formula id="E1">
        <mml:math id="M1">
          <mml:mtable columnalign="left">
            <mml:mtr>
              <mml:mtd>
                <mml:mrow>
                  <mml:mtext>CLscore</mml:mtext>
                  <mml:mo>=</mml:mo>
                  <mml:mfrac>
                    <mml:mrow>
                      <mml:mstyle displaystyle="true">
                        <mml:msubsup>
                          <mml:mo>∑</mml:mo>
                          <mml:mrow>
                            <mml:mtext>i</mml:mtext>
                            <mml:mo>=</mml:mo>
                            <mml:mn>1</mml:mn>
                          </mml:mrow>
                          <mml:mtext>m</mml:mtext>
                        </mml:msubsup>
                        <mml:mrow>
                          <mml:msub>
                            <mml:mrow>
                              <mml:mtext>log</mml:mtext>
                            </mml:mrow>
                            <mml:mrow>
                              <mml:mn>10</mml:mn>
                            </mml:mrow>
                          </mml:msub>
                          <mml:msub>
                            <mml:mrow>
                              <mml:mrow>
                                <mml:mo>(</mml:mo>
                                <mml:mrow>
                                  <mml:msub>
                                    <mml:mi>f</mml:mi>
                                    <mml:mtext>S</mml:mtext>
                                  </mml:msub>
                                </mml:mrow>
                                <mml:mo>)</mml:mo>
                              </mml:mrow>
                            </mml:mrow>
                            <mml:mtext>i</mml:mtext>
                          </mml:msub>
                        </mml:mrow>
                      </mml:mstyle>
                    </mml:mrow>
                    <mml:mtext>N</mml:mtext>
                  </mml:mfrac>
                  <mml:mrow>
                    <mml:mo>|</mml:mo>
                    <mml:mrow>
                      <mml:mtable columnalign="left">
                        <mml:mtr columnalign="left">
                          <mml:mtd columnalign="left">
                            <mml:mrow>
                              <mml:mtext>CLscore</mml:mtext>
                              <mml:mo>:</mml:mo>
                              <mml:mo>=</mml:mo>
                              <mml:mtext>ChEMBL</mml:mtext>
                              <mml:mo>−</mml:mo>
                              <mml:mtext>likeness score</mml:mtext>
                            </mml:mrow>
                          </mml:mtd>
                        </mml:mtr>
                        <mml:mtr columnalign="left">
                          <mml:mtd columnalign="left">
                            <mml:mrow>
                              <mml:mtext>S</mml:mtext>
                              <mml:mo>:</mml:mo>
                              <mml:mo>=</mml:mo>
                              <mml:mtext>shingleinmolecular structure</mml:mtext>
                            </mml:mrow>
                          </mml:mtd>
                        </mml:mtr>
                        <mml:mtr columnalign="left">
                          <mml:mtd columnalign="left">
                            <mml:mrow>
                              <mml:msub>
                                <mml:mi>f</mml:mi>
                                <mml:mtext>S</mml:mtext>
                              </mml:msub>
                              <mml:mo>:</mml:mo>
                              <mml:mo>=</mml:mo>
                              <mml:mtext>abundanceofmolecularshinglein ChEMBL</mml:mtext>
                            </mml:mrow>
                          </mml:mtd>
                        </mml:mtr>
                        <mml:mtr columnalign="left">
                          <mml:mtd columnalign="left">
                            <mml:mrow>
                              <mml:mtext>N</mml:mtext>
                              <mml:mo>:</mml:mo>
                              <mml:mo>=</mml:mo>
                              <mml:mtext>totalnumberofshinglesinmolecular structure</mml:mtext>
                            </mml:mrow>
                          </mml:mtd>
                        </mml:mtr>
                        <mml:mtr columnalign="left">
                          <mml:mtd columnalign="left">
                            <mml:mrow>
                              <mml:mtext>m</mml:mtext>
                              <mml:mo>:</mml:mo>
                              <mml:mo>=</mml:mo>
                              <mml:mtext>numberofshinglessharedwith ChEMBL</mml:mtext>
                            </mml:mrow>
                          </mml:mtd>
                        </mml:mtr>
                      </mml:mtable>
                    </mml:mrow>
                  </mml:mrow>
                </mml:mrow>
              </mml:mtd>
            </mml:mtr>
          </mml:mtable>
        </mml:math>
      </disp-formula>
      <p>The histogram of CLscore for the 457,139 ChEMBL reference molecules is approximately Gaussian with a peak at CLscore = 3.9 (<xref ref-type="fig" rid="F1">Figure 1B</xref>). DrugBank (Law et al., <xref rid="B18" ref-type="bibr">2014</xref>) and particularly ZINC (Sterling and Irwin, <xref rid="B32" ref-type="bibr">2015</xref>) peak at a similar CLscore, showing that these three databases consist of molecules built from the same type of substructures. By contrast GDB17 and its subsets FDB17 and GDBMedChem have a much lower CLscore distribution peaking at CLscore = 2.7, reflecting the fact that GDB molecules are very different from ChEMBL molecules. CLscore values correlate with SAscore values, reflecting the similar principles underlying both scores, and suggesting that molecules with high CLscore should also be synthetically accessible (<xref ref-type="fig" rid="F1">Figure 1D</xref>).</p>
    </sec>
    <sec>
      <title>GDBChEMBL Database</title>
      <p>Calculating CLscores on the entire GDB17 (166.4 billion SMILES) and keeping molecules with CLscore ≥ 3.3, a cut-off value which retains 78.3% of our ChEMBL subset, eliminates 84.3% of GDB17. The remaining 26.2 billion molecules are then binned in triplet value bins considering heavy atom count (HAC 1-17), stereocenter count (0–4, ≥ 5) and heteroatom count (0–8, ≥ 8). There are 538 different triplet value bins, which are occupied by 1 to 1.6 × 10<sup>9</sup> molecules. Uniform sampling finally yields a final set of 10 million molecules evenly distributed across molecular size, stereochemical complexity and polarity, forming the database GDBChEMBL (<xref ref-type="fig" rid="F1">Figure 1E</xref>).</p>
      <p>As a consequence of uniform sampling, the heavy atom count (HAC) profile of GDBChEMBL resembles that of FDB17 and GDBMedChem and is relatively flat compared to the very steep peak at HAC = 17 in the parent database GDB17 (<xref ref-type="fig" rid="F2">Figure 2A</xref>). Uniform sampling also explains the rotatable bond count (RBC) profile in GDB subsets compared to GDB17 (<xref ref-type="fig" rid="F2">Figure 2B</xref>), as well as the fact that the profiles of the three GDB subsets across these parameters are generally more similar to the profile of molecules up to 17 atoms in ChEMBL (ChEMBL17) and to natural products (UNPD17) (Banerjee et al., <xref rid="B7" ref-type="bibr">2015</xref>) than to the profile of GDB17.</p>
      <fig id="F2" position="float">
        <label>Figure 2</label>
        <caption>
          <p><bold>(A)</bold> Heavy atom count (HAC), <bold>(B)</bold> rotatable bonds (ROTB), <bold>(C)</bold> hydrogen bond donors (HBD), <bold>(D)</bold> hydrogen bond acceptors (HBA), <bold>(E)</bold> nitrogen plus oxygen count (N+O), <bold>(F)</bold> topological polar surface area (TPSA), <bold>(G)</bold> computed partition coefficient (aLogP), <bold>(H)</bold> synthetic accessibility score (SAscore), <bold>(I)</bold> Fraction of sp<sup>3</sup> hybridized atoms (fsp<sup>3</sup>), <bold>(J)</bold> natural product likeness score (NPscore), and <bold>(K)</bold> fraction of structures by ring class. Property histograms for GDB17 (black), GDBMedChem (orange), FDB17 (yellow), GDBChEMBL (red), ChEMBL (cpds with HAC ≤ 17, blue) and natural products (cpds with HAC ≤ 17, purple).</p>
        </caption>
        <graphic xlink:href="fchem-08-00046-g0002"/>
      </fig>
      <p>GDBChEMBL displays a very broad distribution in terms of hydrogen bond donor atoms (HBD, <xref ref-type="fig" rid="F2">Figure 2C</xref>), hydrogen bond acceptor atoms (HBA, <xref ref-type="fig" rid="F2">Figure 2D</xref>) and nitrogen plus oxygen atom count (N+O, <xref ref-type="fig" rid="F2">Figure 2E</xref>) due to the absence of heteroatom capping criteria in selecting GDBChEMBL compared to FDB17 and GDBMedChem, for which fragment-likeness criteria, respectively, caps on the number of functional groups were applied. Similar differences are visible in topological polar surface area (TPSA, <xref ref-type="fig" rid="F2">Figure 2F</xref>) and calculated octanol/water partition coefficient (alogP, <xref ref-type="fig" rid="F2">Figure 2G</xref>). The broader distribution of polarity parameters in GDGChEMBL compared to GDB17 results from uniform sampling since the procedure gives relatively more importance to molecules with extreme size and polarity values.</p>
      <p>Synthetic accessibility is better (lower SAscore) in GDBChEMBL than for GDB17, FDB17, or GDBMedChem, reflecting the correlation between CLscore and SAscore noted above (<xref ref-type="fig" rid="F2">Figure 2H</xref>). Similar to GDB17 and its other subsets, GDBChEMBL displays a much higher fraction of sp<sup>3</sup> atoms than ChEMBL (fsp<sup>3</sup>, <xref ref-type="fig" rid="F2">Figure 2I</xref>). As a consequence GDB molecules are closer to natural products, which is reflected in the NPscore profile (<xref ref-type="fig" rid="F2">Figure 2J</xref>). Despite of these differences and similarities in SAscore and NPscore, it must be noted that GDB17 and its subsets stand out by the fact that they contain fewer aromatic and more heterocyclic molecules than ChEMBL and natural products (<xref ref-type="fig" rid="F2">Figure 2K</xref>).</p>
    </sec>
    <sec>
      <title>Visualization and Similarity Searching</title>
      <p>To gain an overview of GDBChEMBL we computed Molecular Quantum Number (MQN) fingerprint values (Nguyen et al., <xref rid="B22" ref-type="bibr">2009</xref>), performed a principal component analysis (Rosén et al., <xref rid="B29" ref-type="bibr">2009</xref>), and visualized the resulting 3D-map in the interactive web-based application faerun (Probst et al., <xref rid="B25" ref-type="bibr">2018</xref>). In this 3D-map accessible at <ext-link ext-link-type="uri" xlink:href="http://faerun.gdb.tools">http://faerun.gdb.tools</ext-link>, each point represents one or more molecules present at the corresponding position and can be color-coded according to a molecular property selected from the faerun menu.</p>
      <p>Comparing MQN maps of GDBChEMBL, FDB17 and GDBMedChem shows that each of the three GDB17 subset cover a similar range of properties, however coverage by GDBChEMBL is more continuous, as is well visible in the vertical stripe at right containing all acyclic molecules (<xref ref-type="fig" rid="F3">Figures 3A–C</xref>). Note that CLscore values are not correlated with MQN properties, which is not surprising considering that ChEMBL substructure span a broad range of properties (<xref ref-type="fig" rid="F3">Figure 3D</xref>). Color-coding by the calculated logP value (alogP, <xref ref-type="fig" rid="F3">Figure 3E</xref>) and by rotatable bond count (RBC, <xref ref-type="fig" rid="F3">Figure 3F</xref>) illustrate the distribution of molecules in the MQN map.</p>
      <fig id="F3" position="float">
        <label>Figure 3</label>
        <caption>
          <p>Chemical space maps of GDBChEMBL, FDB17, and GDBMedChem. <bold>(A)</bold> PCA 3D-map of GDBChEMBL in MQN-space, color coded by heavy atom count; <bold>(B)</bold> same as a for FDB17; <bold>(C)</bold> same as a for GDBMedChem; <bold>(D)</bold> GDBChEMBL color-coded by CLscore value; <bold>(E)</bold> GDBChEMBL color-coded by calculated octanol/water partition coefficient alogP; <bold>(F)</bold> GDBChEMBL color-coded by rotatable bond count; <bold>(G)</bold> similarity map of MQN-nearest neighbors of nicotine from GDBChEMBL (red), FDB17 (cyan), and GDBMedChem (blue). Points in green and yellow indicate molecules shared by two databases. <bold>(H)</bold> Same as g color-coded by Xfp-similarity to nicotine. MQN maps a to f are accessible at <ext-link ext-link-type="uri" xlink:href="http://faerun.gdb.tools">http://faerun.gdb.tools</ext-link>. The similarity map of nicotine analogs g and h is accessible at: <ext-link ext-link-type="uri" xlink:href="http://gdbtools.unibe.ch:8080/webMolCS/">http://gdbtools.unibe.ch:8080/webMolCS/</ext-link>.</p>
        </caption>
        <graphic xlink:href="fchem-08-00046-g0003"/>
      </fig>
      <p>The fact that molecules in GDBChEMBL are substantially different from those in the other subsets FDB17 and GDBMedChem can be shown by retrieving 1,000 MQN-nearest neighbors of nicotine from each database, and representing each dataset in a similarity map (Medina-Franco et al., <xref rid="B20" ref-type="bibr">2007</xref>; Raghavendra and Maggiora, <xref rid="B26" ref-type="bibr">2007</xref>; Awale and Reymond, <xref rid="B4" ref-type="bibr">2015</xref>) using the molecular shape and pharmacophore fingerprint Xfp (Awale and Reymond, <xref rid="B3" ref-type="bibr">2014</xref>), computed with the web-based application WebMolCS (Awale et al., <xref rid="B1" ref-type="bibr">2017a</xref>). This visualization shows that each database provides different types of nicotine analogs (<xref ref-type="fig" rid="F3">Figure 3G</xref>) with a good number of high similarity analogs (<xref ref-type="fig" rid="F3">Figure 3H</xref>). To facilitate similarity searches in GDBChEMBL, we have implemented a similarity search portal by which nearest neighbor searches of any molecule can be performed in GDBChEMBL using MQN, ECFP4, or a combined MQN-MHFP6 similarity, as described previously for GDBMedChem (Awale et al., <xref rid="B5" ref-type="bibr">2019</xref>).</p>
    </sec>
  </sec>
  <sec sec-type="conclusions" id="s3">
    <title>Conclusion</title>
    <p>The data above demonstrate a substructure-based approach to select molecules from the generated database GDB17. As selection criterion we defined a ChEMBL-likeness score (CLscore) from the frequency occurrence of circular substructures, called molecular shingles, in a subset of the database ChEMBL consisting of compounds active on single protein targets with high confidence datapoints. This selection reduced GDB17 by 84.3%, leaving 26.2 billion molecules, which we sampled uniformly across molecular size, stereochemistry and heteroatoms to form GDBChEMBL comprising 10 million molecules.</p>
    <p>Property profiles, chemical space maps and similarity searches show that GDBChEMBL is very different from our earlier GDB subsets FDB17 and GDBMedChem and spans chemical space more continuously. At the same time, the correlation between CLscore and the synthetic accessibility score (SAscore) implies that GDBChEMBL molecules will be on average easier to synthesize than molecules from FDB17 and GDBMedChem, which have significantly lower CLscore and higher SAscores. We anticipate that the requirements for GDBChEMBL molecules to share a minimum number of substructures with molecules of known bioactivities from ChEMBL will also facilitate target prediction and the selection of interesting GDB molecules for synthesis and testing.</p>
  </sec>
  <sec sec-type="methods" id="s4">
    <title>Methods</title>
    <sec>
      <title>Preparative Steps</title>
      <sec>
        <title>ChEMBL Shingle Extraction</title>
        <p>The ChEMBL (v 24.1) database was downloaded from <ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/chembl/">https://www.ebi.ac.uk/chembl/</ext-link>. Data points for extraction of molecular shingles were selected by applying the same restrictions that were used for extraction of training data for our Polypharmacology Browser PPB2 (Visini et al., <xref rid="B35" ref-type="bibr">2017b</xref>). Structures were normalized to their major protonation state at pH 7.4 using ChemAxon cxcalc (v. 18.23.0). Molecular shingles for radii 1–3 were created using RDkit (2019.03.4) and converted to rooted, canonical, aromatic SMILES strings without retaining stereochemistry information. In association with abundancy in the ChEMBL, the SMILES substructures were stored as pickled python dictionary. Molecular substructures that were found &lt;100 times were not stored.</p>
      </sec>
      <sec>
        <title>CLscore Calculation</title>
        <p>Scoring of GDB17 molecular structures was achieved by decomposition to molecular shingles in the exact same way as described for ChEMBL reference shingle extraction. For a specific query structure, all shingles are uniquely counted, then looked up in the ChEMBL reference database and upon match, logarithmic abundancy is summed up. The final CLscore is given by the ratio of total logarithmic abundancies of matched unique shingles to total unique shingles in the query structure. All respective scripts are accessible at: <ext-link ext-link-type="uri" xlink:href="https://github.com/reymond-group/GDBChEMBL">https://github.com/reymond-group/GDBChEMBL</ext-link>.</p>
      </sec>
      <sec>
        <title>GDBChEMBL Generation</title>
        <p>All 166.4 billion molecular structures of GDB17 were decomposed to unique substructures in the same way as described for ChEMBL reference molecules. Only structures with CLscore ≥3.3 were stored. The final GDBChEMBL was obtained by distribution of all filtered 26.2 billion structures to 538 property triplet bins (heavy atom, heteroatom and stereocenter count). Property information was gathered using RDKit. Bins with 5+ hetero atoms and/or 8+ chiral atoms were merged. The actual even sampling was performed by sorting all property bins by size and defining target structure count as 10 million. Iteratively, remaining target count was divided by count of remaining bins, keeping all bins of size smaller than the current number to sample randomly. For each step, number of previously selected structures was subtracted from target count until random sample per remaining bins was lower than bin size. At this point, sample size was kept constant for all further bins.</p>
      </sec>
      <sec>
        <title>Visualizing GDBChEMBL in Faerun</title>
        <p>Property color coded 3D maps for GDBChEMBL, FDB17, and GDBMedChem were generated using FUn (doc.gdb.tools/fun), an in-house developed framework for interactive visualization of chemical spaces on the web. Datasets were given as plain text, consisting of the four columns (space-separated): SMILES-string, numeric ID, 42 MQN descriptors (semicolon-separated) and further molecular properties used for map coloring (semicolon-separated). Next, the preprocessing toolchain was used to project the 42-dimensional MQN-space to 3D by applying Principal Component Analysis (PCA) and to generate all further files needed for visualization. Finally, the Underdark server was run using docker with Faerun visualization containers mapped.</p>
      </sec>
      <sec>
        <title>Similarity Searching in GDBChEMBL</title>
        <p>For better accessibility, GDBChEMBL is provided as a web-based interactive similarity search tool. The implementation uses HTML, Bootstrap, JavaScript, and the python Flask framework. Search times were reduced using Annoy trees (Approximate Nearest Neighbors Oh Yeah, <ext-link ext-link-type="uri" xlink:href="https://github.com/spotify/annoy">https://github.com/spotify/annoy</ext-link>) which were created for the 42-dimensional MQN property space, as well as for 256-bit ECfp4. A third search option, MQN-MHFP6, initially searches using the MQN Annoy tree followed by resorting after Jaccard distance to query molecule in the MHFP6 fingerprint space (<ext-link ext-link-type="uri" xlink:href="https://github.com/reymond-group/mhfp">https://github.com/reymond-group/mhfp</ext-link>). The search tool is available at: <ext-link ext-link-type="uri" xlink:href="https://www.gdb.unibe.ch/tools">gdb.unibe.ch/tools</ext-link>.</p>
      </sec>
    </sec>
  </sec>
  <sec sec-type="data-availability" id="s5">
    <title>Data Availability Statement</title>
    <p>All datasets generated for this study are included in the article/supplementary material.</p>
  </sec>
  <sec id="s6">
    <title>Author Contributions</title>
    <p>SB designed and realized the study and wrote the paper. J-LR designed and supervised the study and wrote the paper.</p>
    <sec>
      <title>Conflict of Interest</title>
      <p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
    </sec>
  </sec>
</body>
<back>
  <fn-group>
    <fn fn-type="financial-disclosure">
      <p><bold>Funding.</bold> This work was supported financially by the Swiss National Science Foundation.</p>
    </fn>
  </fn-group>
  <ref-list>
    <title>References</title>
    <ref id="B1">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Awale</surname><given-names>M.</given-names></name><name><surname>Probst</surname><given-names>D.</given-names></name><name><surname>Reymond</surname><given-names>J. L.</given-names></name></person-group> (<year>2017a</year>). <article-title>WebMolCS: a web-based interface for visualizing molecules in three-dimensional chemical spaces</article-title>. <source>J. Chem. Inf. Model.</source>
<volume>57</volume>, <fpage>643</fpage>–<lpage>649</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jcim.6b00690</pub-id><?supplied-pmid 28316236?><pub-id pub-id-type="pmid">28316236</pub-id></mixed-citation>
    </ref>
    <ref id="B2">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Awale</surname><given-names>M.</given-names></name><name><surname>Reymond</surname><given-names>J.-L.</given-names></name></person-group> (<year>2019</year>). <article-title>Polypharmacology browser PPB2: target prediction combining nearest neighbors with machine learning</article-title>. <source>J. Chem. Inf. Model.</source>
<volume>59</volume>, <fpage>10</fpage>–<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jcim.8b00524</pub-id><?supplied-pmid 30558418?><pub-id pub-id-type="pmid">30558418</pub-id></mixed-citation>
    </ref>
    <ref id="B3">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Awale</surname><given-names>M.</given-names></name><name><surname>Reymond</surname><given-names>J. L.</given-names></name></person-group> (<year>2014</year>). <article-title>Atom pair 2D-fingerprints perceive 3D-molecular shape and pharmacophores for very fast virtual screening of ZINC and GDB-17</article-title>. <source>J. Chem. Inf. Model.</source>
<volume>54</volume>, <fpage>1892</fpage>–<lpage>1897</lpage>. <pub-id pub-id-type="doi">10.1021/ci500232g</pub-id><?supplied-pmid 24988038?><pub-id pub-id-type="pmid">24988038</pub-id></mixed-citation>
    </ref>
    <ref id="B4">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Awale</surname><given-names>M.</given-names></name><name><surname>Reymond</surname><given-names>J. L.</given-names></name></person-group> (<year>2015</year>). <article-title>Similarity mapplet: interactive visualization of the directory of useful decoys and ChEMBL in high dimensional chemical spaces</article-title>. <source>J. Chem. Inf. Model.</source>
<volume>55</volume>, <fpage>1509</fpage>–<lpage>1516</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jcim.5b00182</pub-id><?supplied-pmid 26207526?><pub-id pub-id-type="pmid">26207526</pub-id></mixed-citation>
    </ref>
    <ref id="B5">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Awale</surname><given-names>M.</given-names></name><name><surname>Sirockin</surname><given-names>F.</given-names></name><name><surname>Stiefl</surname><given-names>N.</given-names></name><name><surname>Reymond</surname><given-names>J.-L.</given-names></name></person-group> (<year>2019</year>). <article-title>Medicinal chemistry aware database GDBMedChem</article-title>. <source>Mol. Informatics</source>
<volume>38</volume>:<fpage>1900031</fpage>
<pub-id pub-id-type="doi">10.1002/minf.201900031</pub-id></mixed-citation>
    </ref>
    <ref id="B6">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Awale</surname><given-names>M.</given-names></name><name><surname>Visini</surname><given-names>R.</given-names></name><name><surname>Probst</surname><given-names>D.</given-names></name><name><surname>Arus-Pous</surname><given-names>J.</given-names></name><name><surname>Reymond</surname><given-names>J. L.</given-names></name></person-group> (<year>2017b</year>). <article-title>Chemical space: big data challenge for molecular diversity</article-title>. <source>Chimia</source>
<volume>71</volume>, <fpage>661</fpage>–<lpage>666</lpage>. <pub-id pub-id-type="doi">10.2533/chimia.2017.661</pub-id><?supplied-pmid 29070411?><pub-id pub-id-type="pmid">29070411</pub-id></mixed-citation>
    </ref>
    <ref id="B7">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Banerjee</surname><given-names>P.</given-names></name><name><surname>Erehman</surname><given-names>J.</given-names></name><name><surname>Gohlke</surname><given-names>B.-O.</given-names></name><name><surname>Wilhelm</surname><given-names>T.</given-names></name><name><surname>Preissner</surname><given-names>R.</given-names></name><name><surname>Dunkel</surname><given-names>M.</given-names></name></person-group> (<year>2015</year>). <article-title>Super natural II—a database of natural products</article-title>. <source>Nucleic Acids Res.</source>
<volume>43</volume>, <fpage>D935</fpage>–<lpage>D939</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gku886</pub-id><?supplied-pmid 25300487?><pub-id pub-id-type="pmid">25300487</pub-id></mixed-citation>
    </ref>
    <ref id="B8">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blum</surname><given-names>L. C.</given-names></name><name><surname>Reymond</surname><given-names>J. L.</given-names></name></person-group> (<year>2009</year>). <article-title>970 Million druglike small molecules for virtual screening in the chemical universe database GDB-13</article-title>. <source>J. Am. Chem. Soc</source>. <volume>131</volume>, <fpage>8732</fpage>–<lpage>8733</lpage>. <pub-id pub-id-type="doi">10.1021/ja902302h</pub-id><?supplied-pmid 19505099?><pub-id pub-id-type="pmid">19505099</pub-id></mixed-citation>
    </ref>
    <ref id="B9">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>H.</given-names></name><name><surname>Engkvist</surname><given-names>O.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Olivecrona</surname><given-names>M.</given-names></name><name><surname>Blaschke</surname><given-names>T.</given-names></name></person-group> (<year>2018</year>). <article-title>The rise of deep learning in drug discovery</article-title>. <source>Drug Discovery Today</source>
<volume>23</volume>, <fpage>1241</fpage>–<lpage>1250</lpage>. <pub-id pub-id-type="doi">10.1016/j.drudis.2018.01.039</pub-id><?supplied-pmid 29366762?><pub-id pub-id-type="pmid">29366762</pub-id></mixed-citation>
    </ref>
    <ref id="B10">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Congreve</surname><given-names>M.</given-names></name><name><surname>Carr</surname><given-names>R.</given-names></name><name><surname>Murray</surname><given-names>C.</given-names></name><name><surname>Jhoti</surname><given-names>H.</given-names></name></person-group> (<year>2003</year>). <article-title>A rule of three for fragment-based lead discovery?</article-title>
<source>Drug Discovery Today</source>
<volume>8</volume>, <fpage>876</fpage>–<lpage>877</lpage>. <pub-id pub-id-type="doi">10.1016/S1359-6446(03)02831-9</pub-id><?supplied-pmid 14554012?><pub-id pub-id-type="pmid">14554012</pub-id></mixed-citation>
    </ref>
    <ref id="B11">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elton</surname><given-names>D. C.</given-names></name><name><surname>Boukouvalas</surname><given-names>Z.</given-names></name><name><surname>Fuge</surname><given-names>M. D.</given-names></name><name><surname>Chung</surname><given-names>P. W.</given-names></name></person-group> (<year>2019</year>). <article-title>Deep learning for molecular design—a review of the state of the art</article-title>. <source>Mol. Syst. Des. Eng.</source>
<volume>4</volume>, <fpage>828</fpage>–<lpage>849</lpage>. <pub-id pub-id-type="doi">10.1039/C9ME00039A</pub-id></mixed-citation>
    </ref>
    <ref id="B12">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ertl</surname><given-names>P.</given-names></name><name><surname>Schuffenhauer</surname><given-names>A.</given-names></name></person-group> (<year>2009</year>). <article-title>Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions</article-title>. <source>J. Cheminf.</source>
<volume>1</volume>:<fpage>8</fpage>. <pub-id pub-id-type="doi">10.1186/1758-2946-1-8</pub-id><?supplied-pmid 20298526?><pub-id pub-id-type="pmid">20298526</pub-id></mixed-citation>
    </ref>
    <ref id="B13">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fink</surname><given-names>T.</given-names></name><name><surname>Bruggesser</surname><given-names>H.</given-names></name><name><surname>Reymond</surname><given-names>J. L.</given-names></name></person-group> (<year>2005</year>). <article-title>Virtual exploration of the small-molecule chemical universe below 160 daltons</article-title>. <source>Angew. Chem. Int. Ed. Engl.</source>
<volume>44</volume>, <fpage>1504</fpage>–<lpage>1508</lpage>. <pub-id pub-id-type="doi">10.1002/anie.200462457</pub-id><?supplied-pmid 15674983?><pub-id pub-id-type="pmid">15674983</pub-id></mixed-citation>
    </ref>
    <ref id="B14">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fink</surname><given-names>T.</given-names></name><name><surname>Reymond</surname><given-names>J. L.</given-names></name></person-group> (<year>2007</year>). <article-title>Virtual exploration of the chemical universe up to 11 atoms of C, N, O, F: assembly of 26.4 million structures (110.9 million stereoisomers) and analysis for new ring systems, stereochemistry, physicochemical properties, compound classes, and drug discovery</article-title>. <source>J. Chem. Inf. Model.</source>
<volume>47</volume>, <fpage>342</fpage>–<lpage>353</lpage>. <pub-id pub-id-type="doi">10.1021/ci600423u</pub-id><?supplied-pmid 17260980?><pub-id pub-id-type="pmid">17260980</pub-id></mixed-citation>
    </ref>
    <ref id="B15">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaulton</surname><given-names>A.</given-names></name><name><surname>Hersey</surname><given-names>A.</given-names></name><name><surname>Nowotka</surname><given-names>M.</given-names></name><name><surname>Bento</surname><given-names>A. P.</given-names></name><name><surname>Chambers</surname><given-names>J.</given-names></name><name><surname>Mendez</surname><given-names>D.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title>The ChEMBL database in 2017</article-title>. <source>Nucleic Acids Res.</source><volume>45</volume>, <fpage>D945</fpage>–<lpage>D954</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkw1074</pub-id><?supplied-pmid 27899562?><pub-id pub-id-type="pmid">27899562</pub-id></mixed-citation>
    </ref>
    <ref id="B16">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>Q.</given-names></name><name><surname>Peng</surname><given-names>Z.</given-names></name><name><surname>Kostrowicki</surname><given-names>J.</given-names></name><name><surname>Kuki</surname><given-names>A.</given-names></name></person-group> (<year>2011</year>). <article-title>LEAP into the Pfizer Global Virtual Library (PGVL) space: creation of readily synthesizable design ideas automatically</article-title>. <source>Methods Mol. Biol.</source>
<volume>685</volume>, <fpage>253</fpage>–<lpage>276</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-60761-931-4_13</pub-id><?supplied-pmid 20981528?><pub-id pub-id-type="pmid">20981528</pub-id></mixed-citation>
    </ref>
    <ref id="B17">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jayaseelan</surname><given-names>K. V.</given-names></name><name><surname>Moreno</surname><given-names>P.</given-names></name><name><surname>Truszkowski</surname><given-names>A.</given-names></name><name><surname>Ertl</surname><given-names>P.</given-names></name><name><surname>Steinbeck</surname><given-names>C.</given-names></name></person-group> (<year>2012</year>). <article-title>Natural product-likeness score revisited: an open-source, open-data implementation</article-title>. <source>BMC Bioinformatics</source>
<volume>13</volume>:<fpage>106</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2105-13-106</pub-id><?supplied-pmid 22607271?><pub-id pub-id-type="pmid">22607271</pub-id></mixed-citation>
    </ref>
    <ref id="B18">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Law</surname><given-names>V.</given-names></name><name><surname>Knox</surname><given-names>C.</given-names></name><name><surname>Djoumbou</surname><given-names>Y.</given-names></name><name><surname>Jewison</surname><given-names>T.</given-names></name><name><surname>Guo</surname><given-names>A. C.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>DrugBank 4.0: shedding new light on drug metabolism</article-title>. <source>Nucleic Acids Res.</source><volume>42</volume>, <fpage>D1091</fpage>–<lpage>D1097</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkt1068</pub-id><?supplied-pmid 24203711?><pub-id pub-id-type="pmid">24203711</pub-id></mixed-citation>
    </ref>
    <ref id="B19">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leach</surname><given-names>A. R.</given-names></name><name><surname>Hann</surname><given-names>M. M.</given-names></name></person-group> (<year>2000</year>). <article-title>The <italic>in silico</italic> world of virtual libraries</article-title>. <source>Drug Discov. Today</source>
<volume>5</volume>, <fpage>326</fpage>–<lpage>336</lpage>. <pub-id pub-id-type="doi">10.1016/S1359-6446(00)01516-6</pub-id><?supplied-pmid 10893546?><pub-id pub-id-type="pmid">10893546</pub-id></mixed-citation>
    </ref>
    <ref id="B20">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Medina-Franco</surname><given-names>J. L.</given-names></name><name><surname>Maggiora</surname><given-names>G. M.</given-names></name><name><surname>Giulianotti</surname><given-names>M. A.</given-names></name><name><surname>Pinilla</surname><given-names>C.</given-names></name><name><surname>Houghten</surname><given-names>R. A.</given-names></name></person-group> (<year>2007</year>). <article-title>A similarity-based data-fusion approach to the visual characterization and comparison of compound databases</article-title>. <source>Chem. Biol. Drug Des.</source>
<volume>70</volume>, <fpage>393</fpage>–<lpage>412</lpage>. <pub-id pub-id-type="doi">10.1111/j.1747-0285.2007.00579.x</pub-id><?supplied-pmid 17927720?><pub-id pub-id-type="pmid">17927720</pub-id></mixed-citation>
    </ref>
    <ref id="B21">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mignani</surname><given-names>S.</given-names></name><name><surname>Rodrigues</surname><given-names>J.</given-names></name><name><surname>Tomas</surname><given-names>H.</given-names></name><name><surname>Jalal</surname><given-names>R.</given-names></name><name><surname>Singh</surname><given-names>P. P.</given-names></name><name><surname>Majoral</surname><given-names>J.-P.</given-names></name><etal/></person-group>. (<year>2018</year>). <article-title>Present drug-likeness filters in medicinal chemistry during the hit and lead optimization process: how far can they be simplified?</article-title><source>Drug Discovery Today</source><volume>23</volume>, <fpage>605</fpage>–<lpage>615</lpage>. <pub-id pub-id-type="doi">10.1016/j.drudis.2018.01.010</pub-id><?supplied-pmid 29330127?><pub-id pub-id-type="pmid">29330127</pub-id></mixed-citation>
    </ref>
    <ref id="B22">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>K. T.</given-names></name><name><surname>Blum</surname><given-names>L. C.</given-names></name><name><surname>van Deursen</surname><given-names>R.</given-names></name><name><surname>Reymond</surname><given-names>J.-L.</given-names></name></person-group> (<year>2009</year>). <article-title>Classification of organic molecules by molecular quantum numbers</article-title>. <source>ChemMedChem</source>
<volume>4</volume>, <fpage>1803</fpage>–<lpage>1805</lpage>. <pub-id pub-id-type="doi">10.1002/cmdc.200900317</pub-id><?supplied-pmid 19774591?><pub-id pub-id-type="pmid">19774591</pub-id></mixed-citation>
    </ref>
    <ref id="B23">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poirier</surname><given-names>M.</given-names></name><name><surname>Awale</surname><given-names>M.</given-names></name><name><surname>Roelli</surname><given-names>M. A.</given-names></name><name><surname>Giuffredi</surname><given-names>G. T.</given-names></name><name><surname>Ruddigkeit</surname><given-names>L.</given-names></name><name><surname>Evensen</surname><given-names>L.</given-names></name><etal/></person-group>. (<year>2019</year>). <article-title>Identifying lysophosphatidic acid acyltransferase β (LPAAT-β) as the target of a nanomolar angiogenesis inhibitor from a phenotypic screen using the polypharmacology browser PPB2</article-title>. <source>ChemMedChem</source><volume>14</volume>, <fpage>224</fpage>–<lpage>236</lpage>. <pub-id pub-id-type="doi">10.1002/cmdc.201800554</pub-id><?supplied-pmid 30520265?><pub-id pub-id-type="pmid">30520265</pub-id></mixed-citation>
    </ref>
    <ref id="B24">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Probst</surname><given-names>D.</given-names></name><name><surname>Reymond</surname><given-names>J.-L.</given-names></name></person-group> (<year>2018</year>). <article-title>A probabilistic molecular fingerprint for big data settings</article-title>. <source>J. Cheminf.</source>
<volume>10</volume>:<fpage>66</fpage>. <pub-id pub-id-type="doi">10.1186/s13321-018-0321-8</pub-id><?supplied-pmid 30564943?><pub-id pub-id-type="pmid">30564943</pub-id></mixed-citation>
    </ref>
    <ref id="B25">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Probst</surname><given-names>D.</given-names></name><name><surname>Reymond</surname><given-names>J.-L.</given-names></name><name><surname>Wren</surname><given-names>J.</given-names></name></person-group> (<year>2018</year>). <article-title>FUn: a framework for interactive visualizations of large, high-dimensional datasets on the web</article-title>. <source>Bioinformatics</source>
<volume>34</volume>, <fpage>1433</fpage>–<lpage>1435</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btx760</pub-id><?supplied-pmid 29186333?><pub-id pub-id-type="pmid">29186333</pub-id></mixed-citation>
    </ref>
    <ref id="B26">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raghavendra</surname><given-names>A. S.</given-names></name><name><surname>Maggiora</surname><given-names>G. M.</given-names></name></person-group> (<year>2007</year>). <article-title>Molecular basis sets - a general similarity-based approach for representing chemical spaces</article-title>. <source>J. Chem. Inf. Model.</source>
<volume>47</volume>, <fpage>1328</fpage>–<lpage>1240</lpage>. <pub-id pub-id-type="doi">10.1021/ci600552n</pub-id><?supplied-pmid 17552511?><pub-id pub-id-type="pmid">17552511</pub-id></mixed-citation>
    </ref>
    <ref id="B27">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reymond</surname><given-names>J.-L.</given-names></name></person-group> (<year>2015</year>). <article-title>The chemical space project</article-title>. <source>Acc. Chem. Res.</source>
<volume>48</volume>, <fpage>722</fpage>–<lpage>730</lpage>. <pub-id pub-id-type="doi">10.1021/ar500432k</pub-id><?supplied-pmid 25687211?><pub-id pub-id-type="pmid">25687211</pub-id></mixed-citation>
    </ref>
    <ref id="B28">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riniker</surname><given-names>S.</given-names></name><name><surname>Landrum</surname><given-names>G. A.</given-names></name></person-group> (<year>2013</year>). <article-title>Open-source platform to benchmark fingerprints for ligand-based virtual screening</article-title>. <source>J. Cheminf.</source>
<volume>5</volume>:<fpage>26</fpage>. <pub-id pub-id-type="doi">10.1186/1758-2946-5-26</pub-id><?supplied-pmid 23721588?><pub-id pub-id-type="pmid">23721588</pub-id></mixed-citation>
    </ref>
    <ref id="B29">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosén</surname><given-names>J.</given-names></name><name><surname>Gottfries</surname><given-names>J.</given-names></name><name><surname>Muresan</surname><given-names>S.</given-names></name><name><surname>Backlund</surname><given-names>A.</given-names></name><name><surname>Oprea</surname><given-names>T. I.</given-names></name></person-group> (<year>2009</year>). <article-title>Novel chemical space exploration via natural products</article-title>. <source>J. Med. Chem.</source>
<volume>52</volume>, <fpage>1953</fpage>–<lpage>1962</lpage>. <pub-id pub-id-type="doi">10.1021/jm801514w</pub-id><?supplied-pmid 19265440?><pub-id pub-id-type="pmid">19265440</pub-id></mixed-citation>
    </ref>
    <ref id="B30">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruddigkeit</surname><given-names>L.</given-names></name><name><surname>Blum</surname><given-names>L. C.</given-names></name><name><surname>Reymond</surname><given-names>J. L.</given-names></name></person-group> (<year>2013</year>). <article-title>Visualization and virtual screening of the chemical universe database GDB-17</article-title>. <source>J. Chem. Inf. Model.</source>
<volume>53</volume>, <fpage>56</fpage>–<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1021/ci300535x</pub-id><?supplied-pmid 23259841?><pub-id pub-id-type="pmid">23259841</pub-id></mixed-citation>
    </ref>
    <ref id="B31">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruddigkeit</surname><given-names>L.</given-names></name><name><surname>van Deursen</surname><given-names>R.</given-names></name><name><surname>Blum</surname><given-names>L. C.</given-names></name><name><surname>Reymond</surname><given-names>J. L.</given-names></name></person-group> (<year>2012</year>). <article-title>Enumeration of 166 billion organic small molecules in the chemical universe database GDB-17</article-title>. <source>J. Chem. Inf. Model.</source>
<volume>52</volume>, <fpage>2864</fpage>–<lpage>2875</lpage>. <pub-id pub-id-type="doi">10.1021/ci300415d</pub-id><?supplied-pmid 23088335?><pub-id pub-id-type="pmid">23088335</pub-id></mixed-citation>
    </ref>
    <ref id="B32">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sterling</surname><given-names>T.</given-names></name><name><surname>Irwin</surname><given-names>J. J.</given-names></name></person-group> (<year>2015</year>). <article-title>ZINC 15 – ligand discovery for everyone</article-title>. <source>J. Chem. Inform. Model.</source>
<volume>55</volume>, <fpage>2324</fpage>–<lpage>2337</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jcim.5b00559</pub-id><?supplied-pmid 26479676?><pub-id pub-id-type="pmid">26479676</pub-id></mixed-citation>
    </ref>
    <ref id="B33">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Hilten</surname><given-names>N.</given-names></name><name><surname>Chevillard</surname><given-names>F.</given-names></name><name><surname>Kolb</surname><given-names>P.</given-names></name></person-group> (<year>2019</year>). <article-title>Virtual compound libraries in computer-assisted drug discovery</article-title>. <source>J. Chem. Inf. Model.</source>
<volume>59</volume>, <fpage>644</fpage>–<lpage>651</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jcim.8b00737</pub-id><?supplied-pmid 30624918?><pub-id pub-id-type="pmid">30624918</pub-id></mixed-citation>
    </ref>
    <ref id="B34">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Visini</surname><given-names>R.</given-names></name><name><surname>Arus-Pous</surname><given-names>J.</given-names></name><name><surname>Awale</surname><given-names>M.</given-names></name><name><surname>Reymond</surname><given-names>J. L.</given-names></name></person-group> (<year>2017a</year>). <article-title>Virtual exploration of the ring systems chemical universe</article-title>. <source>J. Chem. Inf. Model.</source>
<volume>57</volume>, <fpage>2707</fpage>–<lpage>2718</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jcim.7b00457</pub-id><?supplied-pmid 29019686?><pub-id pub-id-type="pmid">29019686</pub-id></mixed-citation>
    </ref>
    <ref id="B35">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Visini</surname><given-names>R.</given-names></name><name><surname>Awale</surname><given-names>M.</given-names></name><name><surname>Reymond</surname><given-names>J. L.</given-names></name></person-group> (<year>2017b</year>). <article-title>Fragment database FDB-17</article-title>. <source>J. Chem. Inf. Model.</source>
<volume>57</volume>, <fpage>700</fpage>–<lpage>709</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jcim.7b00020</pub-id><?supplied-pmid 28375006?><pub-id pub-id-type="pmid">28375006</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
